Shoji Takemiya

794 total citations
35 papers, 681 citations indexed

About

Shoji Takemiya is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Shoji Takemiya has authored 35 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 12 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Shoji Takemiya's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Shoji Takemiya is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Shoji Takemiya collaborates with scholars based in Japan, United States and Greece. Shoji Takemiya's co-authors include Yukio Sugimasa, Makoto Akaike, Kazuo Tarao, Setsuo Tamai, Shinichi Ohkawa, Yasushi Rino, Toshio Imada, Muneki Yoshida, Akira Kakita and Akio Shimizu and has published in prestigious journals such as Cancer, Cancer Letters and Patient Education and Counseling.

In The Last Decade

Shoji Takemiya

33 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoji Takemiya Japan 16 352 236 166 154 92 35 681
Yukio Sugimasa Japan 16 288 0.8× 218 0.9× 118 0.7× 198 1.3× 112 1.2× 43 665
Tsutomu Minamino Japan 17 463 1.3× 289 1.2× 229 1.4× 85 0.6× 78 0.8× 33 695
R Pellicci Italy 13 401 1.1× 268 1.1× 181 1.1× 108 0.7× 105 1.1× 40 727
P J Winwood United Kingdom 9 494 1.4× 396 1.7× 189 1.1× 112 0.7× 128 1.4× 13 833
Norio Noguchi Japan 17 345 1.0× 188 0.8× 277 1.7× 266 1.7× 203 2.2× 41 844
Yue Tao China 8 218 0.6× 164 0.7× 235 1.4× 227 1.5× 104 1.1× 13 672
Jürgen Kropf Germany 11 227 0.6× 301 1.3× 200 1.2× 73 0.5× 203 2.2× 13 749
Takao Kojima Japan 10 295 0.8× 314 1.3× 106 0.6× 83 0.5× 233 2.5× 60 881
Alessandro Casini Italy 7 237 0.7× 193 0.8× 158 1.0× 81 0.5× 144 1.6× 9 533
Kouji Tsugawa Japan 16 163 0.5× 125 0.5× 288 1.7× 52 0.3× 149 1.6× 27 607

Countries citing papers authored by Shoji Takemiya

Since Specialization
Citations

This map shows the geographic impact of Shoji Takemiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoji Takemiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoji Takemiya more than expected).

Fields of papers citing papers by Shoji Takemiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoji Takemiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoji Takemiya. The network helps show where Shoji Takemiya may publish in the future.

Co-authorship network of co-authors of Shoji Takemiya

This figure shows the co-authorship network connecting the top 25 collaborators of Shoji Takemiya. A scholar is included among the top collaborators of Shoji Takemiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoji Takemiya. Shoji Takemiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shiozawa, Manabu, Nobuhiro Sugano, Kazuhito Tsuchida, et al.. (2006). Two Cases of Small Cell Carcinoma of the Rectum with Favorable Course by Multidisciplinary Treatment. The Japanese Journal of Gastroenterological Surgery. 39(8). 1446–1451. 2 indexed citations
2.
Yamamoto, Naoto, Teni Godai, Manabu Shiozawa, et al.. (2006). A Case of Metachronous Solitary Splenic Metastasis of Colon Cancer. The Japanese Journal of Gastroenterological Surgery. 39(2). 271–276.
3.
Morinaga, Soichiro, Kazuo Tarao, Yuji Yamamoto, et al.. (2006). Overexpressed cyclo‐oxygenase‐2 in the background liver is associated with the clinical course of hepatitis C virus‐related cirrhosis patients after curative surgery for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 22(8). 1249–1255. 12 indexed citations
4.
Yamada, Roppei, Makoto Akaike, Akira Tsuburaya, et al.. (2005). Water-generated negative air ions activate NK cell and inhibit carcinogenesis in mice. Cancer Letters. 239(2). 190–197. 33 indexed citations
5.
Morinaga, Soichiro, Naoki Ishiwa, Yoshikazu Noguchi, et al.. (2005). Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma. Journal of Surgical Oncology. 92(4). 331–336. 15 indexed citations
6.
Morinaga, Soichiro, Yuji Yamamoto, Yoshikazu Noguchi, et al.. (2004). Platelet-derived endothelial cell growth factor (PD-ECGF) is up-regulated in human hepatocellular carcinoma (HCC) and the corresponding hepatitis liver.. PubMed. 50(53). 1521–6. 9 indexed citations
7.
Sakamoto, Junichi, Yukifumi Kondo, Shoji Takemiya, Nobuaki Sakamoto, & Isamu Nishisho. (2004). A phase II Japanese study of a modified capecitabine regimen for advanced or metastatic colorectal cancer. Anti-Cancer Drugs. 15(2). 137–143. 4 indexed citations
8.
Tarao, Kazuo, Yasushi Rino, Shoji Takemiya, et al.. (2003). Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus‐associated liver cirrhosis. Cancer Science. 94(12). 1083–1090. 10 indexed citations
9.
Yukawa, Norio, et al.. (2002). 42-Month Survival following Chemotherapy for Small-Cell Rectal Carcinoma.. The Japanese Journal of Gastroenterological Surgery. 35(8). 1443–1447. 9 indexed citations
10.
Morinaga, Soichiro, Yuji Yamamoto, Yoshikazu Noguchi, et al.. (2002). Cyclooxygenase‐2 mRNA is up‐regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 17(10). 1110–1116. 38 indexed citations
11.
Shinkai, Masato, Youkatsu Ohhama, Toshiji Nishi, et al.. (2001). Congenital absence of the portal vein and role of liver transplantation in children. Journal of Pediatric Surgery. 36(7). 1026–1031. 88 indexed citations
14.
Tarao, Kazuo, Hiroshi Hoshino, Akio Shimizu, et al.. (1994). Role of Increased DNA Synthesis Activity of Hepatocytes in Multicentric Hepatocarcinogenesis in Residual Liver of Hepatectomized Cirrhotic Patients with Hepatocellular Carcinoma. Japanese Journal of Cancer Research. 85(10). 1040–1044. 30 indexed citations
16.
Ito, Yoshihiko, Kazuo Tarao, Shoji Takemiya, et al.. (1992). Evaluation of BrdU labeling index as a prognostic factor of hepatocellular carcinoma.. Kanzo. 33(10). 751–757. 1 indexed citations
17.
Tarao, Kazuo, Akio Shimizu, Masaoki Harada, et al.. (1991). In vitro uptake of bromodeoxyuridine by human hepatocellular carcinoma and its relation to histopathologic findings and biologic behavior. Cancer. 68(8). 1789–1794. 23 indexed citations
18.
Ito, Yoshihiko, Kazuo Tarao, Akio Shimizu, et al.. (1989). The relation between DNA synthesis estimated by BrdU uptake and Edmondson & Steiner's classification in hepatocellular carcinoma.. Kanzo. 30(5). 538–544. 2 indexed citations
19.
Tarao, Kazuo, Akio Shimizu, Yoshihiko Ito, et al.. (1989). A survey of the super high-risk group of developing hepatocellular carcinoma in cirrhotics: With special reference to DNA synthesis.. Kanzo. 30(8). 866–871. 2 indexed citations
20.
Tarao, Kazuo, Akio Shimizu, Masaoki Harada, et al.. (1989). Difference in thein vitro uptake of bromodeoxyuridine between liver cirrhosis with and without hepatocellular carcinoma. Cancer. 64(1). 104–109. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026